KIR2DL3 and neoplasm: The NK cell receptors, CD335 (NKp46), CD314 (NKG2D) and the killer cell immunoglobulin-like receptors (KIRs) including CD158b, are normally associated with activated NK cell states, T cell co-stimulation, and mediating tumor cell lysis [55,57].